Insud Pharma
Ed Carey has a strong background in quality and compliance roles in the pharmaceutical industry. Ed most recently served as VP & Global Head of Quality & Compliance at Insud Pharma, where they oversaw global operations and played a key role in enhancing product quality and compliance. Prior to this, they held the position of Vice President of Global Quality & Compliance at Apotex Pharmachem Inc., where they led quality assurance and control programs across API manufacturing sites and worked to improve overall quality standards. Ed's earlier experience includes roles at Apotex Inc. and Biovail Corporation, where they focused on defining and supporting quality practices and systems. Ed began their career as a Compliance Associate at Torpharm.
Ed Carey has a Bachelor of Science degree in Biology from Western University. Ed also holds a diploma in Pharmaceutical Quality Assurance from the Toronto Institute of Pharmaceutical Technology.
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.